title: Prognostic factor analysis from EORTC trials in advanced prostatic cancer. EORTC-GU Group.
authors.affiliation: Dpt. of Urology, Free University Hospital, Amsterdam.
authors.forename: H J
authors.initials: HJ
authors.lastname: de Voogt
authors.forename: S
authors.initials: S
authors.lastname: Suciu
authors.forename: R
authors.initials: R
authors.lastname: Sylvester
authors.forename: M
authors.initials: M
authors.lastname: Pavone-Macaluso
authors.forename: P H
authors.initials: PH
authors.lastname: Smith
authors.forename: M
authors.initials: M
authors.lastname: de Pauw
mesh_terms: D000135:Acid Phosphatase / Q000378:metabolism; D000469:Alkaline Phosphatase / Q000378:metabolism; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004961:Estramustine / Q000008:administration & dosage; D006728:Hormones / Q000008:administration & dosage; D006801:Humans; D008297:Male; D015999:Multivariate Analysis; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D006728:Hormones; D004961:Estramustine; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase